Four-Week Pregnant and fasting Blood Glucose is 105 mg/dl

Year 2018, Volume: 6 Issue: 4, 26 - 27, 02.04.2018

Doç. Dr. Esra Hatipoğlu

Abstract

Abstract

Before 24 weeks of pregnancy having fasting glucose levels between 95-125mg/dl is defined as Gestational diabetes. In early diagnosed GDM there is a significant association between fasting glucose and pregnancy associated complications. How ever use of fasting glucose in early pregnancy is controversial dueto high false positive rates. Moreover whether treatment of the cases with early GDM is beneficial or not is unclear. For these reasons we need prospective, multi-center studies in earlier pregnancies to clarify these issues

Keywords

Gestational diabetes, fas-ting glucose, pregnancy

Dört Haftalık Gebe ve Açlık Kan Glukozu 105 mg/dl

Abstract

Öz

24 haftadan önce açlık glukozunun 95-125 mg/dl arasında olması erken Gestasyonel diabetes mellitus (GDM) olarak adlandırılmaktadır. Erken dönemde saptanan GDM olgularında açlık glukozu ile gebelikle ilişkili komplikasyonlar arasında belirgin ilişki olduğunu ortaya konmuştur. Ancak açlık glukozunun erken gebelikte kullanımı yüksek yanlış pozitif oranlar nedeniyle tartışmalı bir konudur. Ayrıca erken GDM li olguların tedaviden fayda görüp görmediği de henüz netleşmemiştir. Bunun için erken gebeliklerde başlayan, prospektif ve çok merkezli çalışmalara ihtiyaç duyulmaktadır.

Keywords

Gestasyonel diyabet, açlıkglukozu, gebelik

References

• Kaynaklar 1.D. S. Epidemiologic context of diabetes in pregnancy. In:McCance D MM, Sacks DA, editor. A practical manual ofdiabetes in pregnancy. London: Blackwell Publishing; 2010. 2.Organization WH. Diagnostic criteria and classification ofhyperglycaemia first detected in pregnancy,WHO/NMH/MND/13.2. Geneva: World health Organiza-tion; 2013. 3.Blumer I, Hadar E, Hadden DR, Jovanovic L, Mestman JH,Murad MH, et al. Diabetes and pregnancy: an endocrinesociety clinical practice guideline. The Journal of clinicalendocrinology and metabolism. 2013;98(11):4227-49.Epub 2013/11/07. doi: 10.1210/jc.2013-2465. PubMedPMID: 24194617. 4.Mills JL, Jovanovic L, Knopp R, Aarons J, Conley M, ParkE, et al. Physiological reduction in fasting plasma gluco-se concentration in the first trimester of normal pregnancy:the diabetes in early pregnancy study. Metabolism: clini-cal and experimental. 1998;47(9):1140-4. Epub 1998/09/29.PubMed PMID: 9751245. 5.Prutsky GJ, Domecq JP, Sundaresh V, Elraiyah T, NabhanM, Prokop LJ, et al. Screening for gestational diabetes: asystematic review and meta-analysis. The Journal of cli-nical endocrinology and metabolism. 2013;98(11):4311-8. Epub 2013/10/24. doi: 10.1210/jc.2013-2460. PubMedPMID: 24151288. 6.Metzger BE, Gabbe SG, Persson B, Buchanan TA, Cata-lano PA, Damm P, et al. International association of dia-betes and pregnancy study groups recommendations on thediagnosis and classification of hyperglycemia in pregnancy.Diabetes care. 2010;33(3):676-82. Epub 2010/03/02. doi:10.2337/dc09-1848. PubMed PMID: 20190296; PubMedCentral PMCID: PMCPMC2827530. 7.Zhu WW, Yang HX, Wei YM, Yan J, Wang ZL, Li XL, et al.Evaluation of the value of fasting plasma glucose in the firstprenatal visit to diagnose gestational diabetes mellitus inchina. Diabetes care. 2013;36(3):586-90. Epub 2012/11/30.doi: 10.2337/dc12-1157. PubMed PMID: 23193214; Pub-Med Central PMCID: PMCPMC3579369. 8.McIntyre HD, Sacks DA, Barbour LA, Feig DS, CatalanoPM, Damm P, et al. Issues With the Diagnosis and Clas-sification of Hyperglycemia in Early Pregnancy. Diabetescare. 2016;39(1):53-4. Epub 2015/11/01. doi: 10.2337/dc15-1887. PubMed PMID: 26519336. 9.Immanuel J, Simmons D. Screening and Treatment forEarly-Onset Gestational Diabetes Mellitus: a SystematicReview and Meta-analysis. Current diabetes reports.2017;17(11):115. Epub 2017/10/04. doi: 10.1007/s11892-017-0943-7. PubMed PMID: 28971305. 10.Metzger BE, Lowe LP, Dyer AR, Trimble ER, ChaovarindrU, Coustan DR, et al. Hyperglycemia and adverse preg-nancy outcomes. The New England journal of medicine.2008;358(19):1991-2002. Epub 2008/05/09. doi:10.1056/NEJMoa0707943. PubMed PMID: 18463375. 11.Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS,Robinson JS. Effect of treatment of gestational diabetes mel-litus on pregnancy outcomes. The New England journal ofmedicine. 2005;352(24):2477-86. Epub 2005/06/14. doi:10.1056/NEJMoa042973. PubMed PMID: 15951574. 12.Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM,Casey B, et al. A multicenter, randomized trial of treatmentfor mild gestational diabetes. The New England journal ofmedicine. 2009;361(14):1339-48. Epub 2009/10/03. doi:10.1056/NEJMoa0902430. PubMed PMID: 19797280; Pub-Med Central PMCID: PMCPMC2804874. 13.Riskin-Mashiah S, Younes G, Damti A, Auslender R.First-trimester fasting hyperglycemia and adverse pregnancyoutcomes. Diabetes care. 2009;32(9):1639-43. Epub2009/06/25. doi: 10.2337/dc09-0688. PubMed PMID:19549728; PubMed Central PMCID: PMCPMC2732138. 14.Hales CN, Barker DJ. Type 2 (non-insulin-dependent) dia-betes mellitus: the thrifty phenotype hypothesis. Diabeto-logia. 1992;35(7):595-601. Epub 1992/07/01. PubMedPMID: 1644236. 15.Cosson E, Carbillon L, Valensi P. High Fasting Plasma Glu-cose during Early Pregnancy: A Review about Early Ge-stational Diabetes Mellitus. Journal of diabetes research.2017;2017:8921712. Epub 2017/11/29. doi:10.1155/2017/8921712. PubMed PMID: 29181414; Pub-Med Central PMCID: PMCPMC5664285.